Safety of Ticagrelor+ Warfarin in Comparison With Clopidogrel+Aspirin+Warfarin

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 296 participants.

Also called NCT02206815

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 296 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02206815
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
China (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02206815. Randomized; no masking; primary purpose treatment. Start 2014-09-19 (actual); primary completion 2019-02-20 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Safety of "Ticagrelor+ Warfarin"in Comparison With "Clopidogrel+Aspirin+Warfarin"
Intervention (Drug)
Ticagrelor+Warfarin
Intervention (Drug)
Clopidogrel+Aspirin+Warfarin
Lead sponsor
Genshan Ma (class: other)
Collaborator
Zhongda Hospital (class: other)

Record details

Record id
cardio:ct-nct02206815
Content hash
f9c580782793539518207d32bfb1fc8fe41785d818b883128c4b821fab4f632d